Guggenheim Capital’s CenterState Bank Corporation Common Stock CSFL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-72,633
Closed -$1.25M 1974
2020
Q1
$1.25M Buy
72,633
+22,599
+45% +$490K 0.01% 992
2019
Q4
$1.25M Buy
50,034
+5,521
+12% +$138K 0.01% 1250
2019
Q3
$1.07M Buy
44,513
+1,211
+3% +$28.3K 0.01% 1299
2019
Q2
$997K Buy
43,302
+4,959
+13% +$116K 0.01% 1359
2019
Q1
$913K Sell
38,343
-345
-0.9% -$8.53K 0.01% 1425
2018
Q4
$814K Buy
38,688
+8,246
+27% +$200K 0.01% 1465
2018
Q3
$854K Buy
30,442
+12,750
+72% +$381K 0.01% 1699
2018
Q2
$528K Buy
+17,692
New +$526K ﹤0.01% 1923
2014
Q3
Sell
-16,948
Closed -$190K 3175
2014
Q2
$190K Sell
16,948
-1,506
-8% -$16.3K ﹤0.01% 2916
2014
Q1
$201K Buy
18,454
+3,165
+21% +$33.7K ﹤0.01% 2889
2013
Q4
$155K Buy
15,289
+819
+6% +$8.38K ﹤0.01% 2902
2013
Q3
$140K Buy
14,470
+265
+2% +$2.56K ﹤0.01% 2799
2013
Q2
$124K Buy
+14,205
New +$120K ﹤0.01% 2805

Other funds holding CSFL

Guggenheim Capital's CSFL Position: Q2 2020 in Review

Guggenheim Capital sold out of CenterState Bank Corporation Common Stock (CSFL) in Q2 2020, closing a stake of 72,633 shares — an estimated $1.25M sold.

Guggenheim Capital first reported a position in CSFL in Q2 2013 and held it in 13 quarters. The position peaked at $1.25M in Q1 2020. 2 funds tracked by Wall St. Rank hold CSFL as of Q2 2020.

  • Guggenheim Capital reported no remaining CenterState Bank Corporation Common Stock position as of Q2 2020 after selling out during the quarter.
  • Guggenheim Capital sold 72,633 CenterState Bank Corporation Common Stock shares in Q2 2020, an estimated $1.25M.
  • Guggenheim Capital first reported a position in CenterState Bank Corporation Common Stock in Q2 2013 and held it in 13 quarters.
  • Guggenheim Capital's CenterState Bank Corporation Common Stock position peaked at $1.25M in Q1 2020.
  • 2 funds tracked by Wall St. Rank held CenterState Bank Corporation Common Stock as of Q2 2020.

Based on Guggenheim Capital's 13F filing for Q2 2020, filed 14 Aug 2020.